Chalice Pharmacies Limited - Accounts to registrar (filleted) - small 18.2

Chalice Pharmacies Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v22.2.0.402 03481415 director 1.2.21 31.1.22 31.1.22 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure034814152021-01-31034814152022-01-31034814152021-02-012022-01-31034814152020-01-31034814152020-02-012021-01-31034814152021-01-3103481415ns16:EnglandWales2021-02-012022-01-3103481415ns15:PoundSterling2021-02-012022-01-3103481415ns11:Director12021-02-012022-01-3103481415ns11:PrivateLimitedCompanyLtd2021-02-012022-01-3103481415ns11:SmallEntities2021-02-012022-01-3103481415ns11:AuditExempt-NoAccountantsReport2021-02-012022-01-3103481415ns11:SmallCompaniesRegimeForDirectorsReport2021-02-012022-01-3103481415ns11:SmallCompaniesRegimeForAccounts2021-02-012022-01-3103481415ns11:FullAccounts2021-02-012022-01-310348141512021-02-012022-01-3103481415ns11:CompanySecretary12021-02-012022-01-3103481415ns11:RegisteredOffice2021-02-012022-01-3103481415ns6:CurrentFinancialInstruments2022-01-3103481415ns6:CurrentFinancialInstruments2021-01-3103481415ns6:Non-currentFinancialInstruments2022-01-3103481415ns6:Non-currentFinancialInstruments2021-01-3103481415ns6:ShareCapital2022-01-3103481415ns6:ShareCapital2021-01-3103481415ns6:RetainedEarningsAccumulatedLosses2022-01-3103481415ns6:RetainedEarningsAccumulatedLosses2021-01-3103481415ns6:NetGoodwill2021-02-012022-01-3103481415ns6:IntangibleAssetsOtherThanGoodwill2021-02-012022-01-3103481415ns6:LongLeaseholdAssetsns6:LandBuildings2021-02-012022-01-3103481415ns6:FurnitureFittings2021-02-012022-01-3103481415ns6:MotorVehicles2021-02-012022-01-3103481415ns6:NetGoodwill2021-01-3103481415ns6:NetGoodwill2022-01-3103481415ns6:NetGoodwill2021-01-3103481415ns6:LongLeaseholdAssetsns6:LandBuildings2021-01-3103481415ns6:FurnitureFittings2021-01-3103481415ns6:MotorVehicles2021-01-3103481415ns6:LongLeaseholdAssetsns6:LandBuildings2022-01-3103481415ns6:FurnitureFittings2022-01-3103481415ns6:MotorVehicles2022-01-3103481415ns6:LongLeaseholdAssetsns6:LandBuildings2021-01-3103481415ns6:FurnitureFittings2021-01-3103481415ns6:MotorVehicles2021-01-3103481415ns6:WithinOneYearns6:CurrentFinancialInstruments2022-01-3103481415ns6:WithinOneYearns6:CurrentFinancialInstruments2021-01-3103481415ns6:RetainedEarningsAccumulatedLosses2021-01-3103481415ns6:RetainedEarningsAccumulatedLosses2021-02-012022-01-3103481415ns11:Director112021-01-3103481415ns11:Director112020-01-3103481415ns11:Director112021-02-012022-01-3103481415ns11:Director112020-02-012021-01-3103481415ns11:Director112022-01-3103481415ns11:Director112021-01-3103481415ns11:Director22021-02-012022-01-31034814152ns11:Director22021-01-31034814152ns11:Director22020-01-31034814152ns11:Director22021-02-012022-01-31034814152ns11:Director22020-02-012021-01-31034814152ns11:Director22022-01-31034814152ns11:Director22021-01-31
REGISTERED NUMBER: 03481415 (England and Wales)




UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2022

FOR

CHALICE PHARMACIES LIMITED

CHALICE PHARMACIES LIMITED (REGISTERED NUMBER: 03481415)






CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 January 2022




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


CHALICE PHARMACIES LIMITED

COMPANY INFORMATION
for the year ended 31 January 2022







DIRECTOR: M S Mann





SECRETARY: Mrs B K Mann





REGISTERED OFFICE: 1110 Elliott Court
Coventry Business Park
Herald Avenue
Coventry
West Midlands
CV5 6UB





REGISTERED NUMBER: 03481415 (England and Wales)





ACCOUNTANTS: LDP Luckmans
1110 Elliott Court
Coventry Business Park
Herald Avenue
Coventry
West Midlands
CV5 6UB

CHALICE PHARMACIES LIMITED (REGISTERED NUMBER: 03481415)

BALANCE SHEET
31 January 2022

2022 2021
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 1,553,315 1,705,873
Tangible assets 5 294,050 344,409
1,847,365 2,050,282

CURRENT ASSETS
Stocks 187,321 178,027
Debtors 6 954,846 864,580
Cash at bank and in hand 605,493 367,518
1,747,660 1,410,125
CREDITORS
Amounts falling due within one year 7 1,179,754 1,150,820
NET CURRENT ASSETS 567,906 259,305
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,415,271

2,309,587

CREDITORS
Amounts falling due after more than one
year

8

(1,889,285

)

(2,032,446

)

PROVISIONS FOR LIABILITIES (48,084 ) (57,433 )
NET ASSETS 477,902 219,708

CAPITAL AND RESERVES
Called up share capital 240 240
Retained earnings 9 477,662 219,468
SHAREHOLDERS' FUNDS 477,902 219,708

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2022 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

CHALICE PHARMACIES LIMITED (REGISTERED NUMBER: 03481415)

BALANCE SHEET - continued
31 January 2022


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 26 September 2022 and were signed by:





M S Mann - Director


CHALICE PHARMACIES LIMITED (REGISTERED NUMBER: 03481415)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 January 2022

1. STATUTORY INFORMATION

Chalice Pharmacies Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 1997, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Long leasehold - 2% on cost
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

CHALICE PHARMACIES LIMITED (REGISTERED NUMBER: 03481415)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 January 2022

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 46 (2021 - 46 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 February 2021
and 31 January 2022 3,051,160
AMORTISATION
At 1 February 2021 1,345,287
Amortisation for year 152,558
At 31 January 2022 1,497,845
NET BOOK VALUE
At 31 January 2022 1,553,315
At 31 January 2021 1,705,873

5. TANGIBLE FIXED ASSETS
Fixtures
Long and Motor
leasehold fittings vehicles Totals
£    £    £    £   
COST
At 1 February 2021
and 31 January 2022 57,679 613,358 68,700 739,737
DEPRECIATION
At 1 February 2021 15,548 349,722 30,058 395,328
Charge for year 1,154 39,545 9,660 50,359
At 31 January 2022 16,702 389,267 39,718 445,687
NET BOOK VALUE
At 31 January 2022 40,977 224,091 28,982 294,050
At 31 January 2021 42,131 263,636 38,642 344,409

CHALICE PHARMACIES LIMITED (REGISTERED NUMBER: 03481415)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 January 2022

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Trade debtors 626,033 706,156
Other debtors 64,157 57,831
Sundry debtors 103,205 3,136
Directors' current accounts 142,000 80,000
Prepayments 19,451 17,457
954,846 864,580

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Bank loans and overdrafts 127,599 128,604
Hire purchase contracts 13,740 13,740
Trade creditors 867,745 862,660
Tax 152,154 110,871
Social security and other taxes 5,644 8,523
Net wages 320 -
Other creditors 1,576 1,762
Accruals and deferred income 361 499
Accrued expenses 10,615 24,161
1,179,754 1,150,820

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2022 2021
£    £   
Bank Loans - More than 1yr 1,872,110 2,001,531
Hire purchase contracts 17,175 30,915
1,889,285 2,032,446

9. RESERVES
Retained
earnings
£   

At 1 February 2021 219,468
Profit for the year 456,194
Dividends (198,000 )
At 31 January 2022 477,662

CHALICE PHARMACIES LIMITED (REGISTERED NUMBER: 03481415)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 January 2022

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 January 2022 and 31 January 2021:

2022 2021
£    £   
M S Mann
Balance outstanding at start of year 62,000 63,463
Amounts advanced 41,500 -
Amounts repaid - (1,463 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 103,500 62,000

B S Atwal
Balance outstanding at start of year 18,000 21,299
Amounts advanced 20,500 -
Amounts repaid - (3,299 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 38,500 18,000